nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—CYP2C18—malignant glioma	0.297	0.421	CbGaD
Desipramine—CYP2B6—malignant glioma	0.221	0.313	CbGaD
Desipramine—SLC6A3—malignant glioma	0.188	0.266	CbGaD
Desipramine—CYP1A2—Carmustine—malignant glioma	0.0368	0.57	CbGbCtD
Desipramine—CYP3A4—Temozolomide—malignant glioma	0.0278	0.431	CbGbCtD
Desipramine—HTR2C—choroid plexus—malignant glioma	0.00869	0.112	CbGeAlD
Desipramine—HTR2A—choroid plexus—malignant glioma	0.00436	0.0561	CbGeAlD
Desipramine—ORM1—vertebral column—malignant glioma	0.00342	0.0439	CbGeAlD
Desipramine—SLC6A3—telencephalic ventricle—malignant glioma	0.00263	0.0339	CbGeAlD
Desipramine—HTR2C—telencephalic ventricle—malignant glioma	0.00255	0.0327	CbGeAlD
Desipramine—HTR2A—cerebellar cortex—malignant glioma	0.0022	0.0282	CbGeAlD
Desipramine—HTR1A—telencephalic ventricle—malignant glioma	0.00214	0.0276	CbGeAlD
Desipramine—Tongue discolouration—Temozolomide—malignant glioma	0.00205	0.047	CcSEcCtD
Desipramine—DRD2—telencephalic ventricle—malignant glioma	0.00194	0.0249	CbGeAlD
Desipramine—HTR2A—pons—malignant glioma	0.00155	0.02	CbGeAlD
Desipramine—HTR2A—vertebral column—malignant glioma	0.00154	0.0198	CbGeAlD
Desipramine—SMPD1—telencephalon—malignant glioma	0.00139	0.0179	CbGeAlD
Desipramine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00131	0.0301	CcSEcCtD
Desipramine—HTR2A—telencephalic ventricle—malignant glioma	0.00128	0.0164	CbGeAlD
Desipramine—Petechiae—Temozolomide—malignant glioma	0.0012	0.0276	CcSEcCtD
Desipramine—HTR2A—pineal body—malignant glioma	0.00111	0.0142	CbGeAlD
Desipramine—Coordination abnormal—Carmustine—malignant glioma	0.00104	0.0239	CcSEcCtD
Desipramine—Coordination abnormal—Temozolomide—malignant glioma	0.00101	0.0231	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00099	0.0227	CcSEcCtD
Desipramine—SMPD1—spinal cord—malignant glioma	0.000973	0.0125	CbGeAlD
Desipramine—Gynaecomastia—Carmustine—malignant glioma	0.000916	0.021	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000826	0.0189	CcSEcCtD
Desipramine—Vascular purpura—Temozolomide—malignant glioma	0.000803	0.0184	CcSEcCtD
Desipramine—SMPD1—central nervous system—malignant glioma	0.00079	0.0101	CbGeAlD
Desipramine—SMPD1—cerebellum—malignant glioma	0.000772	0.00992	CbGeAlD
Desipramine—Purpura—Temozolomide—malignant glioma	0.000745	0.0171	CcSEcCtD
Desipramine—SLC22A3—embryo—malignant glioma	0.000732	0.00941	CbGeAlD
Desipramine—SLC6A3—brainstem—malignant glioma	0.000713	0.00916	CbGeAlD
Desipramine—Ataxia—Carmustine—malignant glioma	0.000699	0.016	CcSEcCtD
Desipramine—HTR2C—brainstem—malignant glioma	0.000689	0.00886	CbGeAlD
Desipramine—Liver function test abnormal—Carmustine—malignant glioma	0.000686	0.0157	CcSEcCtD
Desipramine—HTR2A—endothelium—malignant glioma	0.000686	0.00881	CbGeAlD
Desipramine—Ataxia—Temozolomide—malignant glioma	0.000676	0.0155	CcSEcCtD
Desipramine—CHRM4—central nervous system—malignant glioma	0.000672	0.00864	CbGeAlD
Desipramine—SLC6A4—brainstem—malignant glioma	0.000653	0.0084	CbGeAlD
Desipramine—CHRM2—telencephalon—malignant glioma	0.000634	0.00816	CbGeAlD
Desipramine—SLC6A3—telencephalon—malignant glioma	0.000633	0.00813	CbGeAlD
Desipramine—HTR2A—blood vessel—malignant glioma	0.000632	0.00813	CbGeAlD
Desipramine—SMPD1—brain—malignant glioma	0.000627	0.00806	CbGeAlD
Desipramine—SLC22A1—telencephalon—malignant glioma	0.000623	0.00801	CbGeAlD
Desipramine—HTR2C—telencephalon—malignant glioma	0.000611	0.00786	CbGeAlD
Desipramine—ADRB1—telencephalon—malignant glioma	0.0006	0.00771	CbGeAlD
Desipramine—HTR1A—brainstem—malignant glioma	0.00058	0.00746	CbGeAlD
Desipramine—SLC6A4—telencephalon—malignant glioma	0.00058	0.00745	CbGeAlD
Desipramine—CHRM1—telencephalon—malignant glioma	0.000577	0.00742	CbGeAlD
Desipramine—SLC6A2—brainstem—malignant glioma	0.000575	0.00739	CbGeAlD
Desipramine—Pollakiuria—Temozolomide—malignant glioma	0.000574	0.0132	CcSEcCtD
Desipramine—Erectile dysfunction—Temozolomide—malignant glioma	0.000572	0.0131	CcSEcCtD
Desipramine—Depression—Carmustine—malignant glioma	0.000571	0.0131	CcSEcCtD
Desipramine—Weight increased—Temozolomide—malignant glioma	0.000565	0.013	CcSEcCtD
Desipramine—Neuropathy peripheral—Carmustine—malignant glioma	0.000562	0.0129	CcSEcCtD
Desipramine—Stomatitis—Carmustine—malignant glioma	0.000558	0.0128	CcSEcCtD
Desipramine—Depression—Temozolomide—malignant glioma	0.000552	0.0127	CcSEcCtD
Desipramine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000543	0.0124	CcSEcCtD
Desipramine—Amitriptyline—NTRK2—malignant glioma	0.000541	0.119	CrCbGaD
Desipramine—Stomatitis—Temozolomide—malignant glioma	0.00054	0.0124	CcSEcCtD
Desipramine—CHRM4—brain—malignant glioma	0.000534	0.00686	CbGeAlD
Desipramine—CHRM5—central nervous system—malignant glioma	0.000525	0.00675	CbGeAlD
Desipramine—DRD2—brainstem—malignant glioma	0.000524	0.00674	CbGeAlD
Desipramine—CHRM3—telencephalon—malignant glioma	0.000517	0.00664	CbGeAlD
Desipramine—HTR1A—telencephalon—malignant glioma	0.000515	0.00662	CbGeAlD
Desipramine—Hallucination—Carmustine—malignant glioma	0.000512	0.0117	CcSEcCtD
Desipramine—Hypoaesthesia—Carmustine—malignant glioma	0.000512	0.0117	CcSEcCtD
Desipramine—SLC6A2—telencephalon—malignant glioma	0.00051	0.00656	CbGeAlD
Desipramine—DRD2—retina—malignant glioma	0.000506	0.0065	CbGeAlD
Desipramine—Hepatitis—Temozolomide—malignant glioma	0.000497	0.0114	CcSEcCtD
Desipramine—Hypoaesthesia—Temozolomide—malignant glioma	0.000495	0.0113	CcSEcCtD
Desipramine—Hallucination—Temozolomide—malignant glioma	0.000495	0.0113	CcSEcCtD
Desipramine—HTR2C—medulla oblongata—malignant glioma	0.00048	0.00618	CbGeAlD
Desipramine—Flushing—Carmustine—malignant glioma	0.000477	0.0109	CcSEcCtD
Desipramine—ORM1—spinal cord—malignant glioma	0.000477	0.00613	CbGeAlD
Desipramine—SLC22A5—retina—malignant glioma	0.000471	0.00605	CbGeAlD
Desipramine—DRD2—telencephalon—malignant glioma	0.000465	0.00598	CbGeAlD
Desipramine—Tinnitus—Temozolomide—malignant glioma	0.000463	0.0106	CcSEcCtD
Desipramine—Flushing—Temozolomide—malignant glioma	0.000461	0.0106	CcSEcCtD
Desipramine—Arrhythmia—Carmustine—malignant glioma	0.000459	0.0105	CcSEcCtD
Desipramine—SLC22A4—spinal cord—malignant glioma	0.000459	0.00589	CbGeAlD
Desipramine—Alopecia—Carmustine—malignant glioma	0.000454	0.0104	CcSEcCtD
Desipramine—SLC6A3—midbrain—malignant glioma	0.000454	0.00584	CbGeAlD
Desipramine—SLC6A3—spinal cord—malignant glioma	0.000443	0.0057	CbGeAlD
Desipramine—Alopecia—Temozolomide—malignant glioma	0.000439	0.0101	CcSEcCtD
Desipramine—HTR2C—midbrain—malignant glioma	0.000439	0.00564	CbGeAlD
Desipramine—HTR2C—spinal cord—malignant glioma	0.000428	0.00551	CbGeAlD
Desipramine—Dysgeusia—Temozolomide—malignant glioma	0.000424	0.00972	CcSEcCtD
Desipramine—Vision blurred—Carmustine—malignant glioma	0.000422	0.00968	CcSEcCtD
Desipramine—Tremor—Carmustine—malignant glioma	0.000419	0.00962	CcSEcCtD
Desipramine—CHRM5—brain—malignant glioma	0.000417	0.00536	CbGeAlD
Desipramine—SLC6A4—midbrain—malignant glioma	0.000416	0.00535	CbGeAlD
Desipramine—CYP2A6—cerebellum—malignant glioma	0.000415	0.00533	CbGeAlD
Desipramine—ABCB1—blood vessel—malignant glioma	0.000414	0.00533	CbGeAlD
Desipramine—Agitation—Carmustine—malignant glioma	0.000411	0.00943	CcSEcCtD
Desipramine—Epinastine—CYP2B6—malignant glioma	0.000408	0.09	CrCbGaD
Desipramine—Vision blurred—Temozolomide—malignant glioma	0.000408	0.00935	CcSEcCtD
Desipramine—SLC6A4—spinal cord—malignant glioma	0.000406	0.00522	CbGeAlD
Desipramine—Tremor—Temozolomide—malignant glioma	0.000405	0.00929	CcSEcCtD
Desipramine—Ill-defined disorder—Temozolomide—malignant glioma	0.000401	0.00921	CcSEcCtD
Desipramine—SLC6A2—medulla oblongata—malignant glioma	0.000401	0.00515	CbGeAlD
Desipramine—Agitation—Temozolomide—malignant glioma	0.000398	0.00912	CcSEcCtD
Desipramine—Malaise—Temozolomide—malignant glioma	0.00039	0.00895	CcSEcCtD
Desipramine—Convulsion—Carmustine—malignant glioma	0.000388	0.00889	CcSEcCtD
Desipramine—ORM1—central nervous system—malignant glioma	0.000387	0.00497	CbGeAlD
Desipramine—Hypertension—Carmustine—malignant glioma	0.000387	0.00886	CcSEcCtD
Desipramine—Palpitations—Temozolomide—malignant glioma	0.000382	0.00877	CcSEcCtD
Desipramine—Anxiety—Carmustine—malignant glioma	0.00038	0.00871	CcSEcCtD
Desipramine—HTR2A—embryo—malignant glioma	0.000377	0.00485	CbGeAlD
Desipramine—Convulsion—Temozolomide—malignant glioma	0.000375	0.0086	CcSEcCtD
Desipramine—Hypertension—Temozolomide—malignant glioma	0.000374	0.00857	CcSEcCtD
Desipramine—HTR1A—midbrain—malignant glioma	0.00037	0.00475	CbGeAlD
Desipramine—Confusional state—Carmustine—malignant glioma	0.000368	0.00845	CcSEcCtD
Desipramine—HRH1—telencephalon—malignant glioma	0.000367	0.00472	CbGeAlD
Desipramine—Anxiety—Temozolomide—malignant glioma	0.000367	0.00842	CcSEcCtD
Desipramine—Oedema—Carmustine—malignant glioma	0.000365	0.00838	CcSEcCtD
Desipramine—Discomfort—Temozolomide—malignant glioma	0.000364	0.00835	CcSEcCtD
Desipramine—SLC22A4—cerebellum—malignant glioma	0.000364	0.00467	CbGeAlD
Desipramine—HTR1A—spinal cord—malignant glioma	0.000361	0.00464	CbGeAlD
Desipramine—CHRM2—central nervous system—malignant glioma	0.000361	0.00464	CbGeAlD
Desipramine—Dry mouth—Temozolomide—malignant glioma	0.00036	0.00826	CcSEcCtD
Desipramine—SLC6A3—central nervous system—malignant glioma	0.00036	0.00462	CbGeAlD
Desipramine—Thrombocytopenia—Carmustine—malignant glioma	0.000358	0.0082	CcSEcCtD
Desipramine—Tachycardia—Carmustine—malignant glioma	0.000357	0.00818	CcSEcCtD
Desipramine—Confusional state—Temozolomide—malignant glioma	0.000356	0.00816	CcSEcCtD
Desipramine—SLC22A1—central nervous system—malignant glioma	0.000354	0.00455	CbGeAlD
Desipramine—Oedema—Temozolomide—malignant glioma	0.000353	0.0081	CcSEcCtD
Desipramine—CYP2E1—telencephalon—malignant glioma	0.000353	0.00454	CbGeAlD
Desipramine—SLC6A3—cerebellum—malignant glioma	0.000351	0.00452	CbGeAlD
Desipramine—Anorexia—Carmustine—malignant glioma	0.000348	0.00799	CcSEcCtD
Desipramine—HTR2C—central nervous system—malignant glioma	0.000348	0.00447	CbGeAlD
Desipramine—Thrombocytopenia—Temozolomide—malignant glioma	0.000346	0.00793	CcSEcCtD
Desipramine—HTR2A—brainstem—malignant glioma	0.000346	0.00444	CbGeAlD
Desipramine—Hypotension—Carmustine—malignant glioma	0.000341	0.00783	CcSEcCtD
Desipramine—ADRB1—central nervous system—malignant glioma	0.000341	0.00438	CbGeAlD
Desipramine—SLC22A5—medulla oblongata—malignant glioma	0.00034	0.00437	CbGeAlD
Desipramine—SLC22A3—central nervous system—malignant glioma	0.000339	0.00435	CbGeAlD
Desipramine—CYP2A6—brain—malignant glioma	0.000337	0.00433	CbGeAlD
Desipramine—Anorexia—Temozolomide—malignant glioma	0.000337	0.00772	CcSEcCtD
Desipramine—Amitriptyline—NTRK1—malignant glioma	0.000334	0.0737	CrCbGaD
Desipramine—DRD2—midbrain—malignant glioma	0.000334	0.00429	CbGeAlD
Desipramine—HTR2A—retina—malignant glioma	0.000333	0.00429	CbGeAlD
Desipramine—Insomnia—Carmustine—malignant glioma	0.00033	0.00758	CcSEcCtD
Desipramine—SLC6A4—central nervous system—malignant glioma	0.000329	0.00424	CbGeAlD
Desipramine—CHRM1—central nervous system—malignant glioma	0.000328	0.00422	CbGeAlD
Desipramine—Paraesthesia—Carmustine—malignant glioma	0.000328	0.00752	CcSEcCtD
Desipramine—Somnolence—Carmustine—malignant glioma	0.000325	0.00745	CcSEcCtD
Desipramine—Insomnia—Temozolomide—malignant glioma	0.000319	0.00732	CcSEcCtD
Desipramine—Decreased appetite—Carmustine—malignant glioma	0.000318	0.00728	CcSEcCtD
Desipramine—Paraesthesia—Temozolomide—malignant glioma	0.000317	0.00727	CcSEcCtD
Desipramine—CYP2D6—brainstem—malignant glioma	0.000315	0.00405	CbGeAlD
Desipramine—Somnolence—Temozolomide—malignant glioma	0.000314	0.0072	CcSEcCtD
Desipramine—Constipation—Carmustine—malignant glioma	0.000312	0.00716	CcSEcCtD
Desipramine—SLC22A5—midbrain—malignant glioma	0.000311	0.004	CbGeAlD
Desipramine—Dyspepsia—Temozolomide—malignant glioma	0.000311	0.00713	CcSEcCtD
Desipramine—Decreased appetite—Temozolomide—malignant glioma	0.000307	0.00704	CcSEcCtD
Desipramine—HTR2A—telencephalon—malignant glioma	0.000307	0.00394	CbGeAlD
Desipramine—Ethopropazine—BCHE—malignant glioma	0.000306	0.0675	CrCbGaD
Desipramine—Fatigue—Temozolomide—malignant glioma	0.000304	0.00698	CcSEcCtD
Desipramine—SLC22A5—spinal cord—malignant glioma	0.000303	0.0039	CbGeAlD
Desipramine—Constipation—Temozolomide—malignant glioma	0.000302	0.00692	CcSEcCtD
Desipramine—Feeling abnormal—Carmustine—malignant glioma	0.000301	0.0069	CcSEcCtD
Desipramine—Maprotiline—SLC6A3—malignant glioma	0.0003	0.066	CrCbGaD
Desipramine—SLC22A4—brain—malignant glioma	0.000295	0.0038	CbGeAlD
Desipramine—CHRM3—central nervous system—malignant glioma	0.000294	0.00378	CbGeAlD
Desipramine—HTR1A—central nervous system—malignant glioma	0.000293	0.00376	CbGeAlD
Desipramine—Feeling abnormal—Temozolomide—malignant glioma	0.000291	0.00667	CcSEcCtD
Desipramine—SLC6A2—central nervous system—malignant glioma	0.00029	0.00373	CbGeAlD
Desipramine—Abdominal pain—Carmustine—malignant glioma	0.000289	0.00662	CcSEcCtD
Desipramine—Body temperature increased—Carmustine—malignant glioma	0.000289	0.00662	CcSEcCtD
Desipramine—CHRM2—brain—malignant glioma	0.000286	0.00368	CbGeAlD
Desipramine—HTR1A—cerebellum—malignant glioma	0.000286	0.00368	CbGeAlD
Desipramine—SLC6A3—brain—malignant glioma	0.000285	0.00367	CbGeAlD
Desipramine—SLC22A1—brain—malignant glioma	0.000281	0.00361	CbGeAlD
Desipramine—Urticaria—Temozolomide—malignant glioma	0.000281	0.00643	CcSEcCtD
Desipramine—CYP2D6—telencephalon—malignant glioma	0.000279	0.00359	CbGeAlD
Desipramine—Body temperature increased—Temozolomide—malignant glioma	0.000279	0.0064	CcSEcCtD
Desipramine—Abdominal pain—Temozolomide—malignant glioma	0.000279	0.0064	CcSEcCtD
Desipramine—CYP2E1—medulla oblongata—malignant glioma	0.000277	0.00356	CbGeAlD
Desipramine—HTR2C—brain—malignant glioma	0.000276	0.00355	CbGeAlD
Desipramine—ADRB1—brain—malignant glioma	0.000271	0.00348	CbGeAlD
Desipramine—SLC22A3—brain—malignant glioma	0.000269	0.00345	CbGeAlD
Desipramine—DRD2—central nervous system—malignant glioma	0.000264	0.0034	CbGeAlD
Desipramine—Asthenia—Carmustine—malignant glioma	0.000262	0.00601	CcSEcCtD
Desipramine—SLC6A4—brain—malignant glioma	0.000262	0.00336	CbGeAlD
Desipramine—CHRM1—brain—malignant glioma	0.000261	0.00335	CbGeAlD
Desipramine—DRD2—cerebellum—malignant glioma	0.000258	0.00332	CbGeAlD
Desipramine—Clomipramine—GSTP1—malignant glioma	0.000257	0.0567	CrCbGaD
Desipramine—Carbamazepine—CYP2B6—malignant glioma	0.000256	0.0565	CrCbGaD
Desipramine—Asthenia—Temozolomide—malignant glioma	0.000253	0.00581	CcSEcCtD
Desipramine—Triflupromazine—BCHE—malignant glioma	0.000251	0.0553	CrCbGaD
Desipramine—Diarrhoea—Carmustine—malignant glioma	0.00025	0.00573	CcSEcCtD
Desipramine—Pruritus—Temozolomide—malignant glioma	0.00025	0.00573	CcSEcCtD
Desipramine—CYP2E1—spinal cord—malignant glioma	0.000247	0.00318	CbGeAlD
Desipramine—ABCB1—embryo—malignant glioma	0.000247	0.00318	CbGeAlD
Desipramine—Dizziness—Carmustine—malignant glioma	0.000242	0.00554	CcSEcCtD
Desipramine—Diarrhoea—Temozolomide—malignant glioma	0.000242	0.00554	CcSEcCtD
Desipramine—HTR2A—medulla oblongata—malignant glioma	0.000241	0.0031	CbGeAlD
Desipramine—SLC22A5—cerebellum—malignant glioma	0.000241	0.00309	CbGeAlD
Desipramine—Mianserin—CYP2B6—malignant glioma	0.000236	0.0521	CrCbGaD
Desipramine—Dizziness—Temozolomide—malignant glioma	0.000234	0.00535	CcSEcCtD
Desipramine—CHRM3—brain—malignant glioma	0.000233	0.003	CbGeAlD
Desipramine—Vomiting—Carmustine—malignant glioma	0.000232	0.00533	CcSEcCtD
Desipramine—HTR1A—brain—malignant glioma	0.000232	0.00299	CbGeAlD
Desipramine—Rash—Carmustine—malignant glioma	0.00023	0.00528	CcSEcCtD
Desipramine—SLC6A2—brain—malignant glioma	0.00023	0.00296	CbGeAlD
Desipramine—Dermatitis—Carmustine—malignant glioma	0.00023	0.00528	CcSEcCtD
Desipramine—Headache—Carmustine—malignant glioma	0.000229	0.00525	CcSEcCtD
Desipramine—Vomiting—Temozolomide—malignant glioma	0.000225	0.00515	CcSEcCtD
Desipramine—Rash—Temozolomide—malignant glioma	0.000223	0.00511	CcSEcCtD
Desipramine—Dermatitis—Temozolomide—malignant glioma	0.000222	0.0051	CcSEcCtD
Desipramine—Headache—Temozolomide—malignant glioma	0.000221	0.00507	CcSEcCtD
Desipramine—HTR2A—midbrain—malignant glioma	0.00022	0.00283	CbGeAlD
Desipramine—ABCB1—retina—malignant glioma	0.000219	0.00281	CbGeAlD
Desipramine—Nausea—Carmustine—malignant glioma	0.000217	0.00498	CcSEcCtD
Desipramine—HTR2A—spinal cord—malignant glioma	0.000215	0.00276	CbGeAlD
Desipramine—CYP2B6—central nervous system—malignant glioma	0.000214	0.00275	CbGeAlD
Desipramine—DRD2—brain—malignant glioma	0.00021	0.0027	CbGeAlD
Desipramine—Nausea—Temozolomide—malignant glioma	0.00021	0.00481	CcSEcCtD
Desipramine—HRH1—central nervous system—malignant glioma	0.000209	0.00268	CbGeAlD
Desipramine—Atomoxetine—SLC6A3—malignant glioma	0.000206	0.0454	CrCbGaD
Desipramine—Mianserin—SLC6A3—malignant glioma	0.000201	0.0444	CrCbGaD
Desipramine—ABCB1—telencephalon—malignant glioma	0.000201	0.00258	CbGeAlD
Desipramine—CYP2E1—central nervous system—malignant glioma	0.000201	0.00258	CbGeAlD
Desipramine—Imipramine—CYP2C18—malignant glioma	0.000199	0.0438	CrCbGaD
Desipramine—CYP2E1—cerebellum—malignant glioma	0.000196	0.00252	CbGeAlD
Desipramine—SLC22A5—brain—malignant glioma	0.000195	0.00251	CbGeAlD
Desipramine—Promethazine—CYP2B6—malignant glioma	0.000191	0.0422	CrCbGaD
Desipramine—HTR2A—central nervous system—malignant glioma	0.000174	0.00224	CbGeAlD
Desipramine—HTR2A—cerebellum—malignant glioma	0.00017	0.00219	CbGeAlD
Desipramine—CYP2B6—brain—malignant glioma	0.00017	0.00218	CbGeAlD
Desipramine—Trimipramine—SLC6A3—malignant glioma	0.000169	0.0374	CrCbGaD
Desipramine—HRH1—brain—malignant glioma	0.000166	0.00213	CbGeAlD
Desipramine—CYP3A4—central nervous system—malignant glioma	0.000161	0.00207	CbGeAlD
Desipramine—CYP2E1—brain—malignant glioma	0.000159	0.00205	CbGeAlD
Desipramine—CYP2D6—central nervous system—malignant glioma	0.000159	0.00204	CbGeAlD
Desipramine—ABCB1—medulla oblongata—malignant glioma	0.000158	0.00203	CbGeAlD
Desipramine—CYP2D6—cerebellum—malignant glioma	0.000155	0.002	CbGeAlD
Desipramine—Imipramine—CYP2B6—malignant glioma	0.000147	0.0325	CrCbGaD
Desipramine—Amitriptyline—CYP2B6—malignant glioma	0.000147	0.0323	CrCbGaD
Desipramine—ABCB1—midbrain—malignant glioma	0.000144	0.00186	CbGeAlD
Desipramine—ABCB1—spinal cord—malignant glioma	0.000141	0.00181	CbGeAlD
Desipramine—Nortriptyline—PTGS1—malignant glioma	0.000139	0.0306	CrCbGaD
Desipramine—HTR2A—brain—malignant glioma	0.000138	0.00178	CbGeAlD
Desipramine—CYP2D6—brain—malignant glioma	0.000126	0.00162	CbGeAlD
Desipramine—Imipramine—SLC6A3—malignant glioma	0.000126	0.0277	CrCbGaD
Desipramine—Chlorpromazine—BCHE—malignant glioma	0.000121	0.0267	CrCbGaD
Desipramine—ABCB1—central nervous system—malignant glioma	0.000114	0.00147	CbGeAlD
Desipramine—ABCB1—cerebellum—malignant glioma	0.000112	0.00144	CbGeAlD
Desipramine—ABCB1—brain—malignant glioma	9.07e-05	0.00117	CbGeAlD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	3.48e-06	3.36e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CASP3—malignant glioma	3.46e-06	3.34e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL2—malignant glioma	3.46e-06	3.34e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—MYC—malignant glioma	3.45e-06	3.32e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CASP3—malignant glioma	3.45e-06	3.32e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL2—malignant glioma	3.44e-06	3.32e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—NCOR1—malignant glioma	3.43e-06	3.31e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.43e-06	3.31e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MMP9—malignant glioma	3.42e-06	3.3e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	3.41e-06	3.29e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PTEN—malignant glioma	3.4e-06	3.28e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MDM2—malignant glioma	3.4e-06	3.28e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—RAF1—malignant glioma	3.39e-06	3.27e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EGFR—malignant glioma	3.37e-06	3.25e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—malignant glioma	3.36e-06	3.24e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	3.36e-06	3.24e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ERBB2—malignant glioma	3.35e-06	3.23e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	3.35e-06	3.23e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MMP9—malignant glioma	3.35e-06	3.23e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MDM2—malignant glioma	3.34e-06	3.23e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	3.34e-06	3.22e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MDM2—malignant glioma	3.34e-06	3.22e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTEN—malignant glioma	3.33e-06	3.22e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—RAF1—malignant glioma	3.33e-06	3.21e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	3.33e-06	3.21e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PTEN—malignant glioma	3.33e-06	3.21e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MDM2—malignant glioma	3.33e-06	3.21e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—RAF1—malignant glioma	3.32e-06	3.21e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—malignant glioma	3.32e-06	3.2e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CB—malignant glioma	3.32e-06	3.2e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MDM2—malignant glioma	3.31e-06	3.2e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—RAF1—malignant glioma	3.31e-06	3.2e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	3.31e-06	3.19e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CAV1—malignant glioma	3.3e-06	3.19e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.3e-06	3.19e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—MYC—malignant glioma	3.3e-06	3.18e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	3.3e-06	3.18e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.3e-06	3.18e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ERBB2—malignant glioma	3.29e-06	3.17e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—malignant glioma	3.29e-06	3.17e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.28e-06	3.17e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.28e-06	3.16e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MMP9—malignant glioma	3.27e-06	3.16e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.27e-06	3.16e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.27e-06	3.16e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.27e-06	3.15e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MMP9—malignant glioma	3.26e-06	3.14e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PTEN—malignant glioma	3.25e-06	3.14e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	3.25e-06	3.14e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CB—malignant glioma	3.25e-06	3.14e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—malignant glioma	3.25e-06	3.13e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	3.25e-06	3.13e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PTEN—malignant glioma	3.24e-06	3.12e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.24e-06	3.12e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.24e-06	3.12e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—malignant glioma	3.23e-06	3.11e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.23e-06	3.11e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—malignant glioma	3.22e-06	3.11e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CG—malignant glioma	3.19e-06	3.08e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.19e-06	3.08e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KRAS—malignant glioma	3.18e-06	3.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CXCL8—malignant glioma	3.18e-06	3.07e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	3.17e-06	3.06e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—malignant glioma	3.16e-06	3.05e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	3.16e-06	3.05e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	3.13e-06	3.02e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CXCL8—malignant glioma	3.12e-06	3.01e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.11e-06	3e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	3.1e-06	2.99e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—malignant glioma	3.08e-06	2.97e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—malignant glioma	3.07e-06	2.96e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.07e-06	2.96e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.07e-06	2.96e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KRAS—malignant glioma	3.05e-06	2.94e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—malignant glioma	3.04e-06	2.94e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—malignant glioma	3.04e-06	2.93e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL2—malignant glioma	3.04e-06	2.93e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	3.02e-06	2.91e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	3.01e-06	2.91e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.01e-06	2.9e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—malignant glioma	3.01e-06	2.9e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3e-06	2.9e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	2.99e-06	2.89e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.99e-06	2.89e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.99e-06	2.88e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.99e-06	2.88e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2—malignant glioma	2.98e-06	2.88e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—malignant glioma	2.98e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—malignant glioma	2.98e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2—malignant glioma	2.97e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—malignant glioma	2.97e-06	2.86e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	2.96e-06	2.86e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—malignant glioma	2.96e-06	2.86e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	2.94e-06	2.84e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—malignant glioma	2.94e-06	2.83e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—malignant glioma	2.93e-06	2.83e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	2.93e-06	2.82e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.92e-06	2.82e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—malignant glioma	2.91e-06	2.81e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—malignant glioma	2.9e-06	2.8e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.89e-06	2.79e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.88e-06	2.78e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.88e-06	2.78e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.87e-06	2.77e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—malignant glioma	2.87e-06	2.77e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.86e-06	2.76e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—malignant glioma	2.83e-06	2.73e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.83e-06	2.73e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—malignant glioma	2.83e-06	2.73e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.82e-06	2.72e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—malignant glioma	2.81e-06	2.71e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.81e-06	2.71e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—malignant glioma	2.81e-06	2.71e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—malignant glioma	2.81e-06	2.71e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAT—malignant glioma	2.81e-06	2.71e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.8e-06	2.71e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—malignant glioma	2.8e-06	2.7e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	2.8e-06	2.7e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CAV1—malignant glioma	2.8e-06	2.7e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—malignant glioma	2.8e-06	2.7e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.79e-06	2.69e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—malignant glioma	2.79e-06	2.69e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—malignant glioma	2.78e-06	2.68e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—malignant glioma	2.77e-06	2.67e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—malignant glioma	2.76e-06	2.67e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—malignant glioma	2.76e-06	2.66e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.74e-06	2.65e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.74e-06	2.64e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—malignant glioma	2.73e-06	2.63e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	2.73e-06	2.63e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	2.72e-06	2.62e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—malignant glioma	2.71e-06	2.61e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—malignant glioma	2.7e-06	2.61e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—malignant glioma	2.7e-06	2.61e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.69e-06	2.6e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.69e-06	2.6e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.67e-06	2.58e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.65e-06	2.56e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.65e-06	2.55e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—malignant glioma	2.64e-06	2.55e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.63e-06	2.54e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—malignant glioma	2.61e-06	2.52e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.58e-06	2.49e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—malignant glioma	2.56e-06	2.47e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.55e-06	2.47e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.55e-06	2.46e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—malignant glioma	2.55e-06	2.46e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.54e-06	2.45e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.53e-06	2.44e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	2.53e-06	2.44e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	2.52e-06	2.43e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.51e-06	2.43e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.51e-06	2.42e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.51e-06	2.42e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—malignant glioma	2.51e-06	2.42e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—malignant glioma	2.5e-06	2.41e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—malignant glioma	2.5e-06	2.41e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.49e-06	2.41e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—malignant glioma	2.49e-06	2.4e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.49e-06	2.4e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—malignant glioma	2.48e-06	2.4e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.47e-06	2.38e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—malignant glioma	2.46e-06	2.37e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—malignant glioma	2.45e-06	2.36e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—malignant glioma	2.42e-06	2.34e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	2.4e-06	2.32e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—malignant glioma	2.39e-06	2.31e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—malignant glioma	2.37e-06	2.29e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—malignant glioma	2.35e-06	2.27e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	2.35e-06	2.26e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.34e-06	2.25e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—malignant glioma	2.33e-06	2.25e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—malignant glioma	2.32e-06	2.24e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.32e-06	2.24e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—malignant glioma	2.32e-06	2.24e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—malignant glioma	2.32e-06	2.23e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.31e-06	2.23e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2.3e-06	2.21e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—malignant glioma	2.29e-06	2.21e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.29e-06	2.21e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.29e-06	2.2e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—malignant glioma	2.28e-06	2.2e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	2.28e-06	2.2e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—malignant glioma	2.28e-06	2.2e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.27e-06	2.19e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—malignant glioma	2.27e-06	2.19e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.27e-06	2.19e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.24e-06	2.16e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.24e-06	2.16e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—malignant glioma	2.23e-06	2.15e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—malignant glioma	2.22e-06	2.14e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—malignant glioma	2.21e-06	2.13e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.19e-06	2.12e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—malignant glioma	2.17e-06	2.09e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CAV1—malignant glioma	2.16e-06	2.08e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—malignant glioma	2.16e-06	2.08e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—malignant glioma	2.15e-06	2.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.15e-06	2.07e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.14e-06	2.06e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.12e-06	2.04e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—malignant glioma	2.11e-06	2.04e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—malignant glioma	2.08e-06	2.01e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—malignant glioma	2.05e-06	1.98e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.02e-06	1.95e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2.02e-06	1.94e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—malignant glioma	1.99e-06	1.92e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.98e-06	1.91e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.98e-06	1.91e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.98e-06	1.91e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.97e-06	1.9e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.97e-06	1.9e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.97e-06	1.9e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—malignant glioma	1.96e-06	1.89e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.95e-06	1.89e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—malignant glioma	1.95e-06	1.88e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.95e-06	1.88e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.94e-06	1.87e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—malignant glioma	1.92e-06	1.85e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.92e-06	1.85e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—malignant glioma	1.92e-06	1.85e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—malignant glioma	1.91e-06	1.85e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—malignant glioma	1.91e-06	1.84e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—malignant glioma	1.9e-06	1.84e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—malignant glioma	1.9e-06	1.83e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.88e-06	1.82e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.88e-06	1.81e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.87e-06	1.8e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.73e-06	1.67e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—malignant glioma	1.69e-06	1.63e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—malignant glioma	1.65e-06	1.59e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.65e-06	1.59e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.62e-06	1.56e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—malignant glioma	1.62e-06	1.56e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.62e-06	1.56e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.61e-06	1.55e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.61e-06	1.55e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.59e-06	1.53e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.53e-06	1.47e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.51e-06	1.45e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.49e-06	1.44e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.49e-06	1.44e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.41e-06	1.36e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—malignant glioma	1.3e-06	1.26e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—malignant glioma	1.25e-06	1.2e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—malignant glioma	1.22e-06	1.18e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.19e-06	1.15e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—malignant glioma	1.15e-06	1.11e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—malignant glioma	9.73e-07	9.39e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.19e-07	8.87e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—malignant glioma	7.51e-07	7.24e-06	CbGpPWpGaD
